Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about multiple sclerosis

Recent news which mentions multiple sclerosis

Sanofi's Multiple Sclerosis Antibody Shows Reduction Of Disease Activity
Tickers NEWS SNY
Tags Stories That Matter multiple sclerosis Market News
From Benzinga
Inebriation Remedy And Breakthrough MS Treatment: Meet FSD Pharma
Tickers HUGE
Tags Management General HUGE
From Benzinga
Autism Therapy: Cannformatics Targets Metabolic Imbalances Using Machine Learning
Tickers TECH
Tags Alzheimer's disease Success Stories Cannabis
From Benzinga
A New Music Video "Axolotl Dance" Combines Education and Entertainment
Tags Multiple Sclerosis Axolotl Family
From PRLog
Jazz Pharmaceuticals Analysis Reveals THC And CBD Therapy Alleviates MS Spasticity
Tickers JAZZ
Tags General Jazz Pharmaceuticals CBD Oil
From Benzinga
Promising Multiple Sclerosis Drug Candidate Advances: First Clinical Trial Dosing Completed
Tickers HUGE
Tags Cannabis Markets multiple sclerosis
From Benzinga
Novel Compound Begins Clinical Testing For Potential Treatment Of Multiple Sclerosis
Tickers HUGE
Tags New Chemical Entity Psychedelics Health Care
From Benzinga
How to help loved ones with disabilities during the holidays, from a TV host whose family struggled with aunt's MS diagnosis
Tags Multiple sclerosis Health Tips and Wellness Advice Make It / Life
From CNBC.com News
Michelle Obama's new book puts a spotlight on multiple sclerosis and her father's late diagnosis: Here are 5 early signs of the disease
Tags Multiple sclerosis Make It / Life Neurological disorders
From CNBC.com News
EXCLUSIVE: Pasithea's Multiple Sclerosis Vaccine Candidate Shows Efficacy In Animal Studies, With Potential In Monkeypox
Tickers KTTA
Tags News Biotech General
From Benzinga
Biogen Reveals $900M Settlement In Whistleblower's MS Drug Kickbacks Lawsuit Days Before Trial
Tickers BIIB MS
Tags multiple sclerosis Top Stories Legal
From Benzinga
DEA Sued By Rhode Island Lab Over 'Foot Dragging' On Marijuana Pharmaceutical Licensing, Here's What We Know For Now
Tickers CBD DEA
Tags Cannabis Markets multiple sclerosis
From Benzinga
Novartis Highlights Four-Year Efficacy, Safety Data On Kesimpta In Multiple Sclerosis
Tickers NVS
Tags Market News multiple sclerosis Benzinga
From Benzinga
Living Out Our Commitment for Patients: MS Awareness Month 2022
Tickers BMY
Tags MS Awareness Month Health & Healthcare Responsible Business & Employee Engagement
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Michigan's JARS Cannabis And Others Join Forces To Raise Awareness During MS Awareness Month
Tickers RSO
Tags News RSO JARS Cannabis
From Benzinga
EXCLUSIVE: Pasithea Therapeutics Starts New Multiple Sclerosis Vaccine Development Program
Tickers KTTA
Tags KTTA General Health Care
From Benzinga
Biogen Loses Bid To Revive Tecfidera Drug Patent: Bloomberg
Tickers BIIB VTRS
Tags Market News multiple sclerosis Benzinga
From Benzinga
Europe OKs Biogen's Vumerity For Multiple Sclerosis
Tickers BIIB
Tags BIIB General Health Care
From Benzinga
5 Things You Might Not Know About Apple CEO Tim Cook
Tickers AAPL IBM TECH
Tags IBM AAPL Benzinga
From Benzinga
Why Did AstraZeneca's Alexion Stop Amyotrophic Lateral Sclerosis Trial?
Tickers AZN AZNCF
Tags Briefs News General
From Benzinga
Clene's Stock Gain As Its Nanotherapeutic Improves Energy Production, Brain Utilization In Patients With Parkinson's, Multiple Sclerosis
Tickers CLNN
Tags multiple sclerosis Movers News
From Benzinga
MedRhythms raises $25M to get patients back in tune after a stroke
Tickers TC
Tags Stephen Bruso Brian Harris stroke
From TechCrunch
Biogen, InnoCare Collaborate On Multiple Sclerosis Candidate
Tickers BIIB
Tags Benzinga multiple sclerosis Market News
From Benzinga
Eli Lilly, Verge Genomics Ink $720M Pact For Amyotrophic Lateral Sclerosis Therapies
Tickers LLY
Tags Contracts News Briefs
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.